RFK Jr. said he plans to make substantial changes to a federal program that compensates people who have serious side effects from vaccines and protects manufacturers from being sued https://t.co/AnjcoCyrLF ...

Moderna says its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines https://t.co/93QBuninAV ...

A little known but critically important panel of public health experts, the Advisory Committee on Immunization Practices or ACIP, meets around this time every summer to fine-tune vaccine guidelines. Now, those recommendations usually go straight to the CDC director who typically approves them without any issue. While the committee rarely draws public attention, its work is vital to protecting Americans from vaccinereventable diseases.In fact, countries around the world have modeled their immunization progra ...

Core Viewpoint - Anixa Biosciences, Inc. is set to host an investor webcast on June 26, 2025, to discuss its business strategy, therapeutic portfolio, market opportunities, and upcoming milestones [1][2]. Company Overview - Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention [4]. - The company is developing an ovarian cancer immunotherapy program in collaboration with Moffitt Cancer Center, utilizing a novel CAR-T technology called chimeric endocrine receptor-T cell (CER-T) technology [4]. - Anixa's vaccine portfolio includes vaccines for breast and ovarian cancer developed with Cleveland Clinic, as well as additional vaccines targeting high incidence malignancies in lung, colon, and prostate cancers [4]. - The company partners with renowned research institutions to explore emerging technologies for development and commercialization [4]. Webcast Details - The webcast will feature an introductory presentation by Dr. Amit Kumar, Anixa's Chairman and CEO, followed by a Q&A session for investors [2]. - Interested participants must pre-register to listen to the webcast and ask questions during the live event [3].

Key Takeaways GSK's Specialty Medicines unit drove 19% growth in 2024 and 17% in Q1 2025, led by HIV and oncology drugs. New U.S. approvals and strong research momentum support GSK's pipeline across respiratory, HIV and oncology. GSK trades at a forward P/E of 8.63, below the industry average, and continues to outperform peers and market.GSK (GSK) stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, regulatory and pipeline successes and an opti ...

Welcome to the beat everyone. We're monitoring live pictures from Los Angeles as we come on the air right now. People are continuing these protests after what has widely been reported as the Trump administration's escalation. 700 Marines now deployed by the administration arriving today. You can see some of the indications of this type of military presence on American streets. This is a rare effort to deploy US troops inside the US for what would seem like policing purposes, although the details are in deba ...

Novavax (NVAX) FY Conference June 11, 2025 02:00 PM ET Speaker0 Are we ready to go? Are we live? Oh, hello, everyone. Speaker1 Hi, I'm John Jacobs, CEO of Novavax, and I'm joined here today by Jim Kelly, our CFO, and Doctor. Roxandra Draghia, who heads up our R and D. I want to thank everyone who's here today to join us and listening in to our presentation at the Goldman Sachs forty sixth Annual Global Healthcare Conference. Today's 06/11/2025. I'll advance the slide to our cautionary note regarding forward ...

Medical experts are worried about an aggressive move by HHS Secretary Robert F. Kennedy Jr. . that could completely reshape the country's vaccine policy.The secretary, writing in a Wall Street Journal op-ed, announced that he's removing all 17 members of the CDC's advisory committee on immunization practices. That is an independent panel which consists of medical and public health experts who make recommendations to the CDC about who should get certain vaccines and when, including childhood vaccinations. Jo ...

An updated edition of the April 16, 2025, article.The global cancer treatment market is transforming rapidly, driven by an increasing demand for more effective, less toxic therapies. As per the American Cancer Society, the United States alone is expected to see 2,041,910 new cancer cases and 618,120 cancer-related deaths in 2025. While advances in early detection and treatment have contributed to a decline in mortality rates for certain cancers, the overall rise in cancer incidence continues to push global ...

COM. >> 36 PAST. >> THE HOUR.WELCOME BACK HEALTH AND HUMAN SERVICES SECRETARY ROBERT F KENNEDY JR IS DISMISSING ALL 17 MEMBERS. >> OF. >> THE ADVISORY COMMITTEE.FOR IMMUNIZATION PRACTICES. >> THE PANEL. >> ACTS AS A KEY ADVISOR TO THE CDC.IT ASSESSES THE. >> SAFETY AND. >> CLINICAL NEED FOR VACCINES ACROSS THE COUNTRY.INSURANCE COMPANIES AND GOVERNMENT. >> ASSISTANCE PROGRAMS. >> ARE.>> REQUIRED TO. >> COVER VACCINES. RECOMMENDED BY THE PANEL.>> SECRETARY KENNEDY ANNOUNCED. >> THE MOVE IN AN OPINION PIECE I ...